Lead exposure: Expression and activity levels of Oct-2 in the developing rat brain

Toxicological Sciences

Volumn 95, Issue 2, 2007, Pages 436-442

  Bakheet, Saleh A ^a   Basha, Md Riyaz ^a   Cai, Hui ^b   Zawia, Nasser H ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; Development; Lead; Macroarray; Oct 2

Indexed keywords

ANDROGEN RECEPTOR; COLECALCIFEROL RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEAD ACETATE; MESSENGER RNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 2; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P53; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; STAT2 PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; HIPPOCAMPUS; LEAD POISONING; LONG EVANS RAT; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; ONCOGENE C MYC; POSTNATAL DEVELOPMENT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; FEMALE; HIPPOCAMPUS; LEAD; MALE; OCTAMER TRANSCRIPTION FACTOR-2; ORGANOMETALLIC COMPOUNDS; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; WEANING;

RATTUS;

EID: 33846550807     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl163     Document Type: Article

References (34)

1. Atkins, D. S., Basha, M. R., and Zawia, N. H. (2003). Intracellular signaling pathways involved in mediating the effects of lead on the transcription factor Sp1. Int. J. Dev. Neurosci. 21, 35-44.
2. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998). Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12817-12826.
3. Bakheet, S., and Zawia, N. H. (2002). Temporal changes in the expression of transcription factors in the developing lead-exposed hippocampus as determined by macroarray analysis. Toxicologist 1647.
4. Bakheet, S. A., and Zawia, N. H. (2004). The role of POU domain transcription factors in lead neurotoxicity. In Molecular Neurotoxicology Environmental Agents and Transcription-Transduction Coupling (N. H. Zawia, Ed.), pp. 183-198. CRC press, Boca Raton.
5. Basha, M. R., Murali, M., Siddiqi, H. K., Ghosal, K., Siddiqi, O. K., Lashuel, H.A., Ge, Y.W., Lahiri, D.K., and Zawia, N.H. (2005). Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J. 19, 2083-2084.
6. Basha, M. R., Wei,W., Brydie, M., Razmiafshari, M., and Zawia, N. H. (2003). Lead-induced developmental perturbations in hippocampal Sp1 DNA-binding are prevented by zinc supplementation: In vivo evidence for Pb and Zn competition. Int. J. Develop. Neurosci. 21, 1-12.
7. Bouton, C. M. L. S., and Pevsner, J. (2000). Effects of lead on gene expression. Neurotoxicology 21, 1045-1056.
8. Bressler, J. P., and Goldstein, G. W. (1991). Mechanisms of lead neurotoxicity. Biochem. Pharmacol. 41, 479-484.
9. Brivanlou, A. H., and Darnell, J. E. (2002). Signal transduction and the control of gene expression. Science 295, 813-818.
10. Brown, D. R. (1975). Neonatal lead exposure in the rat: Decreased learning as a function of age and blood lead concentrations. Toxicol. Appl. Pharmacol. 32, 628-637.
11. Chang, W., Chen, J., Wei, Q. Y., and Chen, X. M. (2006). Effects of Brn-3a protein and RNA expression in rat brain following low-level lead exposure during development on spatial learning and memory. Toxicol. Lett. 164, 63-70.
12. Chen, J., Zhu,W., Chen, Q., Lu, L., and Chen, X. (2004). Studies on the effects of lead on the growth and differentiation of hippocampal neural cells as well as the expression of Oct-2. Chin. J. Prev. Med. 38, 151-154.
13. Cory-Slechta, D. A., and Thompson, T. (1979). Behavioral toxicity of chronic postweaning lead exposure in the rat. Toxicol. Appl. Pharmacol. 47, 151-159.
14. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
15. El Yahyaoui, F., Kuster, H., Ben Amor, B., Hohnjec, N., Puhler, A., Becker, A., Gouzy, J., Vernie, T., Gough, C., Niebel, A., et al. (2004). Expression profiling in Medicago truncatula identifies more than 750 genes differentially expressed during nodulation, including many potential regulators of the symbiotic program. Plant Physiol. 136, 3159-3176.
16. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. (2000). Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108, 3-21.
17. Harry, G. J., Schmitt, T. J., Gong, Z., Brown, H., Zawia, N. H., and Evans, H. L. (1996). Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain. Toxicol. Appl. Pharmacol. 139, 84-93.
18. Hossain, M. A., Bouton, C. M. L., Pevsner, J., and Laterrat, J. (2000). Induction of vascular endothelial growth factor in human astrocytes by lead. J. Biol. Chem. 276, 27874-27882.
19. Kim, K., Annadata, M., Goldstein, G. W., and Bressler, J. P. (1997). Induction of c-fos mRNA by lead in PCI2 cells. Int. J. Dev. Neurosci. 15, 175-182.
20. Lanphear, B. P., Dietrich, K., Auinger, P., and Cox, C. (2000). Cognitive deficits associated with blood lead concentrations <10 microg/dl in US children and adolescents. Public Health Res. 115, 521-529.
21. Latchman, D. S. (1999a). The Oct-2 transcription factor. Int. J. Biochem. Cell Biol. 28, 1081-1083.
22. Latchman, D. S. (1999b). POU family transcription factors in the nervous system. J. cell. Physiol. 179, 126-133.
23. Lidsky, T. I., and Schneider, J. S. (2003). Lead neurotoxicity in children: Basic mechanisms and clinical correlates. Brain 126, 5-19.
24. Nunomura, A., Perry, G., Hirai, K., Aliev, G., Takeda, A., Chiba, S., and Smith, M. A. (1999). Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann. NY Acad. Sci. 893, 362-364.
25. Pennypacker, K. R., Xiao, Y., Xu, R. H., and Harry, G. J. (1997). Lead-induced developmental changes in AP-1 DNA binding in rat brain. Int. J. Dev. Neurosci. 15, 321-328.
26. Phillips, K., and Luisi, B. (2000). The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302, 1023-1039.
27. Schmitt, T. J., Zawia, N., and Harry, G. J. (1998). GAP-43 mRNA expression in the developing rat brain: Alterations following lead-acetate exposure. Neurotoxicology 17, 407-414.
28. Sgarlato, G. D., Eastman, C. L., and Sussman, H. H. (2005). Panel of genes transcriptionally up-regulated in squamous cell carcinoma of the cervix identified by representational difference analysis, confirmed by macroarray, and validated by real-time quantitative reverse transcription-PCR. Clin. Chem. 51, 27-34.
29. Smith, D., Bayer, L., and Strupp, B. J. (1998). Efficacy of succimer chelation for reducing brain Pb levels in a rodent model. Environ. Res. 78, 168-176.
30. Weber, A., and Jung, K. (2002). Profiling early osmostress-dependent gene expression in Escherichia coli using DNA macroarrays. J. Bacteriol. 184, 5502-5507.
31. Zawia, N. H. (2003). Transcriptional involvement in neurotoxicity. Toxicol. Appl. Pharmacol. 190, 177-188.
32. Zawia, N. H., Evers, L. B., and Harry, G. J. (1994). Developmental profiles of ornithine decarboxylase activity in the hippocampus, neocortex and cerebellum: Modulation following lead exposure. Int. J. Dev. Neurosci. 12, 25-30.
33. Zawia, N. H., and Harry, G. J. (1996). Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol. Appl. Pharmacol. 138, 43-47.
34. Zawia, N. H., Sharan, R., Brydie, M., Oyama, T., and Crumpton, T. (1998). SP1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression. Brain Res. 107, 291-298.